How Do I Diagnose Chronic Myelomonocytic Leukemia (CMML)? MediCom Oncology Clinical Pearls Podcasts podcast

Artwork

Oncology Medicine MediCom Oncology Multiple Myeloma Science

Player FM - Internet Radio Done Right

40 subscribers

eight 年前已添加！

内容由MediCom Oncology提供。所有播客内容（包括剧集、图形和播客描述）均由 MediCom Oncology 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品，您可以按照此处概述的流程进行操作https://zh.player.fm/legal。

T

This Is Woman's Work with Nicole Kalil

This Is Woman's Work with Nicole Kalil podcast artwork

This Is Woman's Work with Nicole Kalil podcast artwork

1
QUALIFIED: How Competency Checking and Race Collide at Work with Shari Dunn | 284 33:58

3天之前33:58

33:58

In this episode, we delve into the concept of being "qualified" in the workplace, examining who gets labeled as such, who doesn't, and the underlying reasons. We explore "competency checking"—the practice of scrutinizing individuals' abilities—and how it disproportionately affects underrepresented groups, often going unnoticed or unchallenged. Our discussion aims to redefine qualifications in a fair, equitable, and actionable manner. Our guest, Shari Dunn , is an accomplished journalist, former attorney, news anchor, CEO, university professor, and sought-after speaker. She has been recognized as Executive of the Year and a Woman of Influence, with her work appearing in Fortune Magazine, The Wall Street Journal, Ad Age, and more. Her new book, Qualified: How Competency Checking and Race Collide at Work , unpacks what it truly means to be deserving and capable—and why systemic barriers, not personal deficits, are often the real problem. Her insights challenge the narratives that hold so many of us back and offer practical solutions for building a more equitable future. Together, we can build workplaces and communities that don’t just reflect the world we live in, but the one we want to create. A world where being qualified is about recognizing the talent and potential that’s been overlooked for far too long. It’s not just about getting a seat at the table—it’s about building an entirely new table, one designed with space for all of us. Connect with Our Guest Shari Dunn Website& Book - Qualified: https://thesharidunn.com LI: https://www.linkedin.com/today/author/sharidunn TikTok: https://www.tiktok.com/@thesharidunn Related Podcast Episodes: How To Build Emotionally Mature Leaders with Dr. Christie Smith | 272 Holding It Together: Women As America's Safety Net with Jessica Calarco | 215 How To Defy Expectations with Dr. Sunita Sah | 271 Share the Love: If you found this episode insightful, please share it with a friend, tag us on social media, and leave a review on your favorite podcast platform! 🔗 Subscribe & Review: Apple Podcasts | Spotify | Amazon Music…

MediCom Oncology Clinical Pearls Podcasts « »
How do I diagnose chronic myelomonocytic leukemia (CMML)?

8年之前 3:35

分享

MP3•单集首页

内容由MediCom Oncology提供。所有播客内容（包括剧集、图形和播客描述）均由 MediCom Oncology 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品，您可以按照此处概述的流程进行操作https://zh.player.fm/legal。

Listen as Dr. Rami Komrokji explains how to diagnose chronic myelomonocytic leukemia (CMML).

… continue reading

53集单集

#Oncology #Medicine #MediCom Oncology #Multiple Myeloma #Science

Artwork

How do I diagnose chronic myelomonocytic leukemia (CMML)?

MediCom Oncology Clinical Pearls Podcasts

40 subscribers

published 8年之前

分享

MP3•单集首页

内容由MediCom Oncology提供。所有播客内容（包括剧集、图形和播客描述）均由 MediCom Oncology 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品，您可以按照此处概述的流程进行操作https://zh.player.fm/legal。

Listen as Dr. Rami Komrokji explains how to diagnose chronic myelomonocytic leukemia (CMML).

… continue reading

53集单集

#Oncology #Medicine #MediCom Oncology #Multiple Myeloma #Science

Wszystkie odcinki

×

1
Third-generation FLT3 inhibitors in clinical development 2:42

6 years之前2:42

2:42

Dr. Perl provides a brief summary of what is on the horizon for FLT3 inhibitors in AML.

1
CAR T case study in acute myeloid leukemia 5:49

6 years之前5:49

5:49

Dr. Sallman describes a patient case demonstrating promise in the further study and potential use of CAR T-cell therapy for patients with AML.

1
Key considerations when prescribing midostaurin with a strong CYP3A4 inhibi 2:23

6 years之前2:23

2:23

Dr. Perl gives guidance on providing optimal patient therapy when prescribing midostaurin with a strong CYP3A4 inhibitor.

1
How to proceed with a patient who presents with idiopathic cytopenia of undetermined significance 3:58

7 years之前3:58

3:58

In this audio activity, Dr. Goldberg describes his approach to patients with idiopathic or clonal cytopenias of undetermined significance (ICUS and CCUS).

1
When to consider iron chelation therapy for a transplant-eligible patient 3:56

7 years之前3:56

3:56

Listen as Dr. Goldberg explains his approach to iron chelation therapy in patients who are, or may be within the next 5-10 years, eligible for transplant.

1
53-year-old woman presenting with severe fatigue and bruising 3:58

7 years之前3:58

3:58

Hematopathologist Dr. Khoury presents a case snapshot showing the complexities of diagnosing AML, describing the importance of morphology, flow cytometry, cytogenetics, and molecular diagnostics.

1
New subcategories of pancreatic cancer allow for a biomarker-driven approach to therapy 4:00

7 years之前4:00

4:00

Dr. O'Reilly discusses the new subcategories of pancreatic cancer that have emerged, and which are laying the groundwork for a biomarker-driven approach to therapy.

1
What are the unique aspects of pancreas cancer that lead to the development of novel therapeutics? 2:40

7 years之前2:40

2:40

Dr. O'Reilly discusses the unique pathophysiology of pancreas cancer that must be considered in the development of novel therapeutics.

1
Predictors of response to lenalidomide in a non-del(5q) MDS patient 3:03

7 years之前3:03

3:03

Listen as Dr. Goldberg discusses, in just under two minutes, the predictors of response to lenalidomide in a non-del(5q) MDS patient.

1
What are the pros and cons of radiation therapy? 2:29

7 years之前2:29

2:29

Listen as Dr. Matasar discusses the pros and cons of radiation therapy, and who should be offered this therapy.

1
What defines high-quality survivorship care for patients treated for classical Hodgkin lymphoma? 3:01

7 years之前3:01

3:01

Listen as Dr. Matasar discusses survivorship care for patients who have been treated for classical Hodgkin lymphoma, including late effects of treatment.

1
Second primary malignancies associated with lenalidomide maintenance 2:53

7 years之前2:53

2:53

Dr. Jacob Laubach discusses second primary malignancies associated with lenalidomide maintenance in the transplant and post-transplant setting.

1
Impact of consolidation therapy in patients post-transplant 3:09

7 years之前3:09

3:09

Dr. Laubach discusses the impact of consolidation therapy in patients post-transplant, referencing results of the CTN StaMINA trial.

1
Bortezomib as an alternate strategy for maintenance therapy. 2:32

7 years之前2:32

2:32

Dr. Jacob Laubach discusses bortezomib as an alternate strategy to lenalidomide for maintenance therapy in patients with multiple myeloma.

1
What may be the future role for brentuximab vedotin in newly diagnosed Hodgkin lymphoma? 2:35

7 years之前2:35

2:35

Listen as Dr. Matasar discusses the future role of brentuximab vedotin in patients with newly diagnosed classical Hodgkin lymphoma.

欢迎使用Player FM

Player FM正在网上搜索高质量的播客，以便您现在享受。它是最好的播客应用程序，适用于安卓、iPhone和网络。注册以跨设备同步订阅。

收听超过500个主题

边探索边听这个节目